305 related articles for article (PubMed ID: 38255791)
1. In silico analysis of overall survival with YBX1 in male and female solid tumours.
Grimes DR; Rassamegevanon T; Marignol L
Sci Rep; 2024 Mar; 14(1):7218. PubMed ID: 38538658
[TBL] [Abstract][Full Text] [Related]
2. Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential.
Dinh NTM; Nguyen TM; Park MK; Lee CH
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255791
[TBL] [Abstract][Full Text] [Related]
3. PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.
Hartley AV; Wang B; Mundade R; Jiang G; Sun M; Wei H; Sun S; Liu Y; Lu T
Sci Rep; 2020 Sep; 10(1):15934. PubMed ID: 32985589
[TBL] [Abstract][Full Text] [Related]
4. Role of post-translational modification of the Y box binding protein 1 in human cancers.
Prabhu L; Hartley AV; Martin M; Warsame F; Sun E; Lu T
Genes Dis; 2015 Sep; 2(3):240-246. PubMed ID: 30258867
[TBL] [Abstract][Full Text] [Related]
5. Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.
Lin C; Lin P; Yao H; Liu S; Lin X; He R; Teng Z; Zuo X; Li Y; Ye J; Zhu G
Cancer Lett; 2024 Apr; 587():216712. PubMed ID: 38364962
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.
Kuwano M; Shibata T; Watari K; Ono M
Cancer Sci; 2019 May; 110(5):1536-1543. PubMed ID: 30903644
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
[TBL] [Abstract][Full Text] [Related]
8. YBX1, Targeted By Microrna-382-5p, Promotes Laryngeal Squamous Cell Carcinoma Progression
Zeng W; Pan Y; Chen H; Lei X; Zhang X
Recent Pat Anticancer Drug Discov; 2024; 19(2):176-187. PubMed ID: 38214357
[TBL] [Abstract][Full Text] [Related]
9. YBX1 Regulates Satellite II RNA Loading into Small Extracellular Vesicles and Promotes the Senescent Phenotype.
Chiba M; Miyata K; Okawa H; Tanaka Y; Ueda K; Seimiya H; Takahashi A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003589
[TBL] [Abstract][Full Text] [Related]
10. IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma.
Ru J; Lu J; Ge J; Ding B; Su R; Jiang Y; Sun Y; Ma J; Li Y; Sun J; Xu G; Tong R; Zheng S; Yang B; Wu J
Cancer Lett; 2024 Jan; 581():216495. PubMed ID: 37993085
[TBL] [Abstract][Full Text] [Related]
11. Neural Stem Cell Extracellular Vesicles Carrying YBX1 Inhibited Neuronal Pyroptosis Through Increasing m6A-modified GPR30 Stability and Expression in Ischemic Stroke.
Peng J; He J; Lin L; Li Y; Xia Y
Transl Stroke Res; 2023 Nov; ():. PubMed ID: 37966628
[TBL] [Abstract][Full Text] [Related]
12. PIN1P1 is activated by CREB1 and promotes gastric cancer progression via interacting with YBX1 and upregulating PIN1.
Wang YW; Zhu WJ; Ma RR; Tian YR; Chen X; Gao P
J Cell Mol Med; 2024 Jan; 28(1):e18022. PubMed ID: 37929660
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
